Exact Mass: 510.273
Exact Mass Matches: 510.273
Found 500 metabolites which its exact mass value is equals to given mass value 510.273
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Physagulin A
Physagulin A is found in fruits. Physagulin A is a constituent of the famine food Physalis angulata (cutleaf ground cherry).
(2S,3S,4R)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
Butanediamide, N4-(5-(acetylamino)-1-((methylamino)carbonyl)pentyl)-N1-hydroxy-2-(((4-hydroxyphenyl)thio)methyl)-3-(2-methylpropyl)-, (2S-(N4(R*),2R*,3S*))-
PA(2:0/18:1(12Z)-2OH(9,10))
PA(2:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(12Z)-2OH(9,10)/2:0)
PA(18:1(12Z)-2OH(9,10)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/2:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Schweinfurthin H
A stilbenoid isolated from Macaranga alnifolia and has been shwon to exhibit cytotoxic activity.
16-Diacetoxy-7alpha-hydroxy-18-malonyloxy-ent-cleroda-3-ene
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid
(20R)-15alpha-hydroxy-8beta,9alpha,14alpha,17alpha-pregn-4-en-3-one 20-O-beta-D-glucopyranoside
(2beta,3beta,5beta,22R)-2,3,14,20,22,25-Hexahydroxy-6-oxocholest-7-en-26-oic acid
11-hydroxy-7Halpha,10Hbeta-eremophil-4(15)-ene 11-O-beta-D-(3-O,4-O,6-O-triacetyl)glucopyranoside
6beta-cinnamoyl--5alpha,7beta-dihydroxy-12,16-epoxy-12alpha-methoxycassa-13(15)-en-16-one|neocaesalpin G
16beta-acetoxy-6alpha,7alpha-epoxy-5alpha-hydroxy-1-oxowitha-2,17(20),24-trienolide
3a-hydroxy-8-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indole-2-carboxylic acid 2-acetoxy-8a-hydroxy-5-isopropenyl-3,8-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl ester|fischerindoline
17-hydroxypregnanolone-glucuronide|O1-(17-hydroxy-20-oxo-5beta-pregnan-3alpha-yl)-beta-D-glucopyranuronic acid|O1-(17-Hydroxy-20-oxo-5beta-pregnan-3alpha-yl)-beta-D-glucopyranuronsaeure
5beta-myrtenyl-9alpha-hydroxy-4,5-dihydroatripliciolide-8-O-angelate
ent-15,16-trihydroxypimar-8(14)-en-3-yl beta-glucopyranoside-15,16-acetonide
His Gln Ala Arg
His Gln Val Lys
Zeylasterone
Zeylasterone is a natural product found in Maytenus woodsonii, Kokoona reflexa, and Celastrus paniculatus with data available.
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate [IIN-based: Match]
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate [IIN-based on: CCMSLIB00000847843]
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid [IIN-based on: CCMSLIB00000845468]
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate [IIN-based: Match]
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid [IIN-based: Match]
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate [IIN-based on: CCMSLIB00000847198]
Ala His Gln Arg
Ala His Arg Gln
Ala Gln His Arg
Ala Gln Arg His
Ala Arg His Gln
Ala Arg Gln His
Cys Ile Ile Tyr
Cys Ile Leu Tyr
Cys Ile Tyr Ile
Cys Ile Tyr Leu
Cys Leu Ile Tyr
Cys Leu Leu Tyr
Cys Leu Tyr Ile
Cys Leu Tyr Leu
Cys Tyr Ile Ile
Cys Tyr Ile Leu
Cys Tyr Leu Ile
Cys Tyr Leu Leu
Glu His Ile Ile
Glu His Ile Leu
Glu His Leu Ile
Glu His Leu Leu
Glu Ile His Ile
Glu Ile His Leu
Glu Ile Ile His
Glu Ile Leu His
Glu Leu His Ile
Glu Leu His Leu
Glu Leu Ile His
Glu Leu Leu His
Phe Phe Val Val
Phe Ile Met Thr
Phe Ile Thr Met
Phe Leu Met Thr
Phe Leu Thr Met
Phe Met Ile Thr
Phe Met Leu Thr
Phe Met Thr Ile
Phe Val Phe Val
Phe Val Val Phe
His Ala Gln Arg
His Ala Arg Gln
His Glu Ile Ile
His Glu Ile Leu
His Glu Leu Ile
His Glu Leu Leu
His Ile Glu Ile
His Ile Glu Leu
His Ile Ile Glu
His Ile Lys Asn
His Ile Leu Glu
His Ile Asn Lys
His Ile Asn Gln
His Ile Gln Asn
His Lys Ile Asn
His Lys Leu Asn
His Lys Asn Ile
His Lys Asn Leu
His Lys Gln Val
His Lys Val Gln
His Leu Glu Ile
His Leu Glu Leu
His Leu Ile Glu
His Leu Lys Asn
His Leu Leu Glu
His Leu Asn Lys
His Leu Asn Gln
His Leu Gln Asn
His Asn Ile Lys
His Asn Ile Gln
His Asn Lys Ile
His Asn Lys Leu
His Asn Leu Lys
His Asn Leu Gln
His Asn Gln Ile
His Asn Gln Leu
His Gln Ile Asn
His Gln Lys Val
His Gln Leu Asn
His Gln Asn Ile
His Gln Asn Leu
His Gln Gln Val
His Gln Arg Ala
His Gln Val Gln
His Arg Ala Gln
His Arg Gln Ala
His Val Lys Gln
His Val Gln Lys
His Val Gln Gln
Ile Glu His Ile
Ile Glu His Leu
Ile Glu Ile His
Ile Glu Leu His
Ile His Glu Ile
Ile His Glu Leu
Ile His Ile Glu
Ile His Lys Asn
Ile His Leu Glu
Ile His Asn Lys
Ile His Asn Gln
Ile His Gln Asn
Ile Ile Glu His
Ile Ile His Glu
Ile Lys His Asn
Ile Lys Asn His
Ile Leu Glu His
Ile Leu His Glu
Ile Asn His Lys
Ile Asn His Gln
Ile Asn Lys His
Ile Asn Gln His
Ile Gln His Asn
Ile Gln Asn His
Ile Tyr Leu Cys
Lys His Ile Asn
Lys His Leu Asn
Lys His Asn Ile
Lys His Asn Leu
Lys His Gln Val
Lys His Val Gln
Lys Ile His Asn
Lys Ile Asn His
Lys Leu His Asn
Lys Leu Asn His
Lys Asn His Ile
Lys Asn His Leu
Lys Asn Ile His
Lys Asn Leu His
Lys Gln His Val
Lys Gln Val His
Lys Val His Gln
Lys Val Gln His
Leu Glu His Ile
Leu Glu His Leu
Leu Glu Ile His
Leu Glu Leu His
Leu His Glu Ile
Leu His Glu Leu
Leu His Ile Glu
Leu His Lys Asn
Leu His Leu Glu
Leu His Asn Lys
Leu His Asn Gln
Leu His Gln Asn
Leu Ile Glu His
Leu Ile His Glu
Leu Lys His Asn
Leu Lys Asn His
Leu Leu Glu His
Leu Leu His Glu
Leu Asn His Lys
Leu Asn His Gln
Leu Asn Lys His
Leu Asn Gln His
Leu Gln His Asn
Leu Gln Asn His
Met Phe Thr Ile
Met Phe Thr Leu
Met Ile Phe Thr
Met Ile Thr Phe
Met Leu Phe Thr
Met Leu Thr Phe
Met Thr Phe Ile
Met Thr Ile Phe
Met Thr Leu Phe
Met Val Val Tyr
Met Val Tyr Val
Met Tyr Val Val
Asn His Ile Lys
Asn His Ile Gln
Asn His Lys Ile
Asn His Lys Leu
Asn His Leu Lys
Asn His Leu Gln
Asn His Gln Ile
Asn His Gln Leu
Asn Ile His Lys
Asn Ile His Gln
Asn Ile Lys His
Asn Ile Gln His
Asn Lys His Ile
Asn Lys His Leu
Asn Lys Ile His
Asn Lys Leu His
Asn Leu His Lys
Asn Leu His Gln
Asn Leu Lys His
Asn Leu Gln His
Asn Gln His Ile
Asn Gln His Leu
Asn Gln Ile His
Asn Gln Leu His
Gln Ala His Arg
Gln Ala Arg His
Gln His Ala Arg
Gln His Ile Asn
Gln His Lys Val
Gln His Leu Asn
Gln His Asn Ile
Gln His Asn Leu
Gln His Gln Val
Gln His Arg Ala
Gln His Val Lys
Gln His Val Gln
Gln Ile His Asn
Gln Ile Asn His
Gln Lys His Val
Gln Lys Val His
Gln Leu His Asn
Gln Leu Asn His
Gln Asn His Ile
Gln Asn His Leu
Gln Asn Ile His
Gln Asn Leu His
Gln Gln His Val
Gln Gln Val His
Gln Arg Ala His
Gln Arg His Ala
Gln Val His Lys
Gln Val His Gln
Gln Val Lys His
Gln Val Gln His
Arg Ala His Gln
Arg Ala Gln His
Arg His Ala Gln
Arg His Gln Ala
Arg Gln Ala His
Arg Gln His Ala
Thr Phe Ile Met
Thr Phe Leu Met
Thr Phe Met Ile
Thr Phe Met Leu
Thr Ile Phe Met
Thr Ile Met Phe
Thr Leu Phe Met
Thr Leu Met Phe
Thr Met Phe Ile
Thr Met Phe Leu
Thr Met Ile Phe
Thr Met Leu Phe
Val Phe Phe Val
Val Phe Val Phe
Val His Lys Gln
Val His Gln Lys
Val His Gln Gln
Val Lys His Gln
Val Lys Gln His
Val Met Val Tyr
Val Met Tyr Val
Val Gln His Lys
Val Gln His Gln
Val Gln Lys His
Val Gln Gln His
Val Val Phe Phe
Val Val Met Tyr
Val Val Tyr Met
Val Tyr Met Val
Val Tyr Val Met
Tyr Cys Ile Ile
Tyr Cys Ile Leu
Tyr Cys Leu Ile
Tyr Cys Leu Leu
Tyr Ile Cys Ile
Tyr Ile Cys Leu
Tyr Ile Ile Cys
Tyr Ile Leu Cys
Tyr Leu Cys Ile
Tyr Leu Cys Leu
Tyr Leu Ile Cys
Tyr Leu Leu Cys
Tyr Met Val Val
Tyr Val Met Val
Tyr Val Val Met
Leukotriene D4 methyl ester
Physagulin A
Ethyl acrylate-acrylic acid-2-ethylhexyl acrylate-N-methylolacrylamide-acrylonitrile polymer
Atrasentan
C28313 - Endothelin Receptor Antagonist > C28334 - Endothelin Receptor Type A Antagonist D065128 - Endothelin Receptor Antagonists > D065130 - Endothelin A Receptor Antagonists D000970 - Antineoplastic Agents
N-(butoxymethyl)prop-2-enamide,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enenitrile,2-methylprop-2-enoic acid
Tetrahydroasterriquinone
A member of the class of dihydroxy-1,4-benzoquinones that is asterriquinone in which the double bonds in both of the N-(3-methylbut-1-en-3-yl) groups have been reduced to single bonds.
(2S,3S,4R)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
(5R)-2,5,6-trihydroxy-2-methyl-6-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[(4R,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
[3-Methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
[(2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate
methyl 6-O-[15-(ethyldisulfanyl)pentadecanoyl]-beta-D-galactoside
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-pentadec-9-enoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
nebramycin 5
A carbamoylkanamycin that is tobramycin bearing a single carbamoyl substituent located at position 6 (on the 3-aminoglucose ring).
(3r,4r,4's,6r,6''s,9s,9''s,9ar,9''ar)-6,6''-bis(furan-3-yl)-9,9''-dimethyl-hexadecahydrodispiro[quinolizine-3,2'-thiolane-4',3''-quinolizin]-4-ol
(1s,2r,4r,6s,7s,10r,11r,16r,17r,18s)-18-(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-17-yl acetate
2-[(2-{[2-(2-amino-n,3-dimethylbutanamido)-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-4-methylpentylidene)amino]benzoic acid
(2s,5z)-2-methyl-4-oxo-6-[(1r,3r,5s,10s,14r,15r,18r)-6,6,10,14,18-pentamethyl-7,13,17-trioxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-15-yl]hept-5-enoic acid
(6bs,8as,11r,12ar,12bs,14ar)-2,3-dihydroxy-11-(methoxycarbonyl)-6b,8a,11,12b,14a-pentamethyl-5-oxo-7,8,9,10,12,12a,13,14-octahydropicene-4-carboxylic acid
2-{[(2s)-2-{[(2r)-2-[(2s,3r)-2-amino-n,3-dimethylpentanamido]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-methylbutylidene]amino}benzoic acid
(1s,2r,7s,9r,11r,12r,13s,16r)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-13-yl acetate
(1r,2r,4s,10s,11r,13s,14r,19r)-1,11-dihydroxy-9,9,14-trimethyl-17-[(1r)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-18-methylidene-3,8-dioxapentacyclo[11.7.0.0²,⁴.0⁴,¹⁰.0¹⁴,¹⁹]icosa-5,16-dien-7-one
(3r,4s,4'r,6s,6''s,9r,9''r,9as,9''as)-6,6''-bis(furan-3-yl)-9,9''-dimethyl-hexadecahydrodispiro[quinolizine-3,2'-thiolane-4',3''-quinolizin]-4-ol
(2r)-2-{[(2s)-2-{[(2r)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-phenylpropanoic acid
3-(4-{3-hydroxy-3a,6,6,9a,11a-pentamethyl-4,7,10-trioxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}furan-2-yl)-2-methylpropanoic acid
(3e,5e,7s,8r,10s,15r,16z,18z,24s)-11-ethyl-7,20,24,27,28-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,5,16,18,20,26-heptaen-2-one
(1e,3z,5z,7s,8r,9s,10s,11s,13r,15s,16z,18z,24s,25s)-11-ethyl-2,7,20,24,27-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,5,16,18,20,26-heptaen-28-one
methyl (2s,4as,6ar,12br,14as,14br)-9-formyl-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-3,8-dioxo-4,5,6,6b,7,13,14,14b-octahydro-1h-picene-2-carboxylate
6-hydroxythiobinupharidine
{"Ingredient_id": "HBIN012470","Ingredient_name": "6-hydroxythiobinupharidine","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)SC3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19420;19421;19422","PubChem_id": "9936153","DrugBank_id": "NA"}
6-hydroxythionuphlutine b
{"Ingredient_id": "HBIN012471","Ingredient_name": "6-hydroxythionuphlutine b","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)SC3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19424;19425;19426","PubChem_id": "10984042","DrugBank_id": "NA"}
6'-hydroxythionuphlutine b
{"Ingredient_id": "HBIN012472","Ingredient_name": "6'-hydroxythionuphlutine b","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)CS3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19423","PubChem_id": "10164525","DrugBank_id": "NA"}
applanoxidic acid F
{"Ingredient_id": "HBIN016523","Ingredient_name": "applanoxidic acid F","Alias": "NA","Ingredient_formula": "C30H38O7","Ingredient_Smile": "CC(CC(=O)C=C(C)C1CC(=O)C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)C(=O)O","Ingredient_weight": "510.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38765","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101664507","DrugBank_id": "NA"}